News

ValGenesis, Inc and LifeBee have partnered to deliver best-in-class business consulting and innovative digital validation solutions in GxP regulated areas such as manufacturing, quality assurance, laboratories, logistics, serialization, regulatory affairs and pharmacovigilance for biopharmaceutical, medical devices, and nutraceutical companies across Italy and Switzerland.

The company is building out a new, GMP-compliant facility for a new fermented product being brought to market. The company will implement the VLMS for equipment qualification and use ValGenesis e-Logbook for continuous monitoring of the equipment at their new facility.

“Implementing a digital validation lifecycle management solution as soon as a company opens its doors is rare. But we increasingly find that new age life sciences startups are determined to leverage digital automation and other smart factory capabilities from the outset,” says Dr. Siva Samy, CEO at ValGenesis.

ValGenesis CEO and Chief Product Strategist Dr. Siva Samy kicked off this year’s conference with an overview of 2022 and the product roadmap for 2023 and beyond.

In this partnership, QbD Pharmaceutical Services will implement and manage next-generation digital risk management, process validation verification tools developed by ValGenesis, enabling clients to further strengthen quality by design and process validation and verification across the GMP lifecycle. Both companies are working to release the full potential of digital transformation for clients, providing them with the best course for success in the new digital validation landscape.

ValGenesis, Inc and Xevalics Consulting have partnered to deliver best-in-class digital validation solutions for the life sciences industry across the U.S.

ValGenesis Inc. announces the final speaker lineup of ValConnect 2022, its annual user conference that runs from Monday, September 26th through Wednesday September 28th.

ValGenesis, Inc and Enhanced Information Solutions (EIS) have partnered to deliver best-in-class digital validation solutions for the life sciences industry across the U.S. and Europe.

The acquisition was initiated when ValGenesis leadership saw the strategic product synergy for customers requiring a complete and more integrated platform across the validation lifecycle focusing on Pharma 4.0.